Literature DB >> 30681727

Alloimmunogenicity of an isolated MHC allele is affected by the context of MHC mismatch in a murine model.

Krystalyn E Hudson1,2, Andrea S L Wong1, Amanda L Richards1, Linda M Kapp1, James C Zimring1,2,3.   

Abstract

BACKGROUND: Humoral alloimmunization to human leukocyte antigen (HLA) can represent a barrier to solid-organ transplantation, can lead to a refractory state in patients requiring platelet transfusion, and can also contribute to transfusion-related acute lung injury (TRALI). While exposure to HLA-mismatched cells/tissues are generally required for HLA alloimmunization, the effect of the extent of major histocompatibility complex (MHC) mismatch between donor and recipient is poorly understood. STUDY DESIGN AND METHODS: A novel mouse was generated that allows the expression of a single MHC Class I alloantigen, Kd . Alloimmune responses to Kd were studied in C57BL/6 mice transfused with splenocytes from different donor mice, allowing the analysis of responses to Kd as an isolated alloantigen, or in the context of additional mismatched MHC molecules. Advanced tools were utilized to study responses to Kd , including T-cell receptor transgenic mice that recognize the immunodominant Kd peptide presented by C57BL/6 mice to CD4+ T cells.
RESULTS: A single MHC Class I alloantigen mismatch is less immunogenic than when the same alloantigen is encountered in the context of additional mismatched MHC alloantigens. This difference is due, at least in part, to induction of CD4+ helper T cells, as the effect is overcome by increasing either mature CD4+ T-cell help through immunization or by increasing the precursor frequency of naïve CD4+ T cells by adoptive transfer from T-cell receptor transgenic donors.
CONCLUSION: These findings indicate that the immunogenicity of a single alloantigen can be affected by the context in which it is encountered, demonstrating the potential for cooperative effects between different mismatched MHC alloantigens.
© 2019 AABB.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30681727      PMCID: PMC7025900          DOI: 10.1111/trf.15109

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  27 in total

Review 1.  Anti-HLA antibodies after solid organ transplantation.

Authors:  R M McKenna; S K Takemoto; P I Terasaki
Journal:  Transplantation       Date:  2000-02-15       Impact factor: 4.939

2.  A synaptic basis for paracrine interleukin-2 signaling during homotypic T cell interaction.

Authors:  Catherine A Sabatos; Junsang Doh; Sumone Chakravarti; Rachel S Friedman; Priya G Pandurangi; Aaron J Tooley; Matthew F Krummel
Journal:  Immunity       Date:  2008-07-31       Impact factor: 31.745

Review 3.  Antibody-mediated transfusion-related acute lung injury; from discovery to prevention.

Authors:  Anna L Peters; Danielle Van Stein; Alexander P J Vlaar
Journal:  Br J Haematol       Date:  2015-04-28       Impact factor: 6.998

4.  Immune responsiveness against allogeneic platelet transfusions is determined by the recipient's major histocompatibility complex class II phenotype.

Authors:  Ebrahim Sayeh; Rukshana Aslam; Edwin R Speck; Hoang Le-Tien; Alan H Lazarus; John Freedman; John W Semple
Journal:  Transfusion       Date:  2004-11       Impact factor: 3.157

Review 5.  A brief history of T cell help to B cells.

Authors:  Shane Crotty
Journal:  Nat Rev Immunol       Date:  2015-02-13       Impact factor: 53.106

6.  Extreme leukoreduction of major histocompatibility complex class II positive B cells enhances allogeneic platelet immunity.

Authors:  J W Semple; E R Speck; D Cosgrave; A H Lazarus; V S Blanchette; J Freedman
Journal:  Blood       Date:  1999-01-15       Impact factor: 22.113

7.  Antibodies in transplantation: the effects of HLA and non-HLA antibody binding and mechanisms of injury.

Authors:  Nicole M Valenzuela; Elaine F Reed
Journal:  Methods Mol Biol       Date:  2013

8.  Outcome of kidney transplantations performed with preformed donor-specific antibodies of unknown etiology.

Authors:  A Sicard; L Amrouche; C Suberbielle; M Carmagnat; S Candon; E Thervet; M Delahousse; C Legendre; L Chatenoud; R Snanoudj
Journal:  Am J Transplant       Date:  2013-11-13       Impact factor: 8.086

9.  Differences in immunogenicity of HLA antigens and the impact of cross-reactivity on the humoral response.

Authors:  Donna P Lucas; Mary S Leffell; Andrea A Zachary
Journal:  Transplantation       Date:  2015-01       Impact factor: 4.939

10.  An adjustable predictive score of graft survival in kidney transplant patients and the levels of risk linked to de novo donor-specific anti-HLA antibodies.

Authors:  Aurélie Prémaud; Matthieu Filloux; Philippe Gatault; Antoine Thierry; Matthias Büchler; Eliza Munteanu; Pierre Marquet; Marie Essig; Annick Rousseau
Journal:  PLoS One       Date:  2017-07-03       Impact factor: 3.240

View more
  1 in total

1.  A small allelic variant in donor class I MHC is sufficient to induce alloantibodies following transfusion of standard or pathogen-reduced platelets in mice.

Authors:  Rachael P Jackman; John W Heitman; Marcus O Muench
Journal:  Vox Sang       Date:  2020-03-23       Impact factor: 2.144

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.